Latvian fund LongeVC invests in British startup Constructive Bio

Latvian fund LongeVC has invested in Cambridge-based biotech startup Constructive Bio. 

Constructive Bio is a company specializing in synthetic biology and biotechnology. The company's main services are the creation of synthetic genomes and reprogramming of genetic codes of living organisms, which allows the production of programmable biomolecules. Constructive Bio was founded in 2022 in Cambridge, UK, by Professor Jason Chin.

Constructive Bio will use the investment raised to develop scalable solutions for the next generation of biologically-based therapeutics and materials.

Founded in 2016 by Garri Zmudze, Sergey Jakimov, and Ilya Suharenko, LongeVC is a venture company with offices in Riga and Lugano (Switzerland). A €35M fund backs startups at the early and seed stage startups in the US and Europe.